Role of Salbutamol and Furosemide in TTN

• Status: Completed
• Trial end date: 2017-06-30
• Target enrollment: 0
• Participant gender: All

Summary

to see the effects of slabutamol and IV furosemide in the treatment of transient tachypnea of newborn

• Phase: Phase 3
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Armed Forces Hospital, Pakistan
• Treatments: Albuterol; Furosemide

Criteria

Inclusion Criteria:

• all newborn babies with clinically diagnosed TTN

Exclusion Criteria:

• babies less than 34 weeks babies with congenital malformations and CHD